May 13 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O:
LEXICON PHARMACEUTICALS Q1 OPERATING INCOME USD -25.679 MILLION
LEXICON PHARMACEUTICALS Q1 OPERATING EXPENSES USD 26.941 MILLION
LEXICON PHARMACEUTICALS Q1 NET INCOME USD -25.295 MILLION
LEXICON PHARMACEUTICALS Q1 BASIC EPS USD -0.07
LEXICON PHARMACEUTICALS INC: ON TRACK FOR NEXT STEPS IN PILAVAPADIN'S DEVELOPMENT, INCLUDING OUR END OF PHASE 2 MEETING WITH FDA